Biotech's Comeback Kid

Embedded Link

Biotech’s Comeback Kid – Forbes
After languishing in the shadow of Genentech for years, Biogen, with a new CEO, a promising new drug and a soaring share price, could be the next big thing in the drug business.

Google+: View post on Google+


Comments are closed.